Glaxosmi. Pharma (GLAXO)
FAST GROWERFairStock Score: 60/100 — STEADY
Score breakdown: P/E: 0/3 · ROCE: 2/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹2,494.6 |
| Market Cap | ₹43,564.46 Cr |
| P/E Ratio | 43.31 |
| ROCE | 63.25% |
| ROE | 52.32% |
| Dividend Yield | 1.63% |
| Profit Growth | 18.83% |
| Debt/Equity | 0.02 |
| Sales Growth | 2.59% |
| Free Cash Flow | ₹1,24,400 Cr |
| Promoter Holding | 75% |
| 52-Week Range | ₹2,088.1 — ₹3,500 |
| Sector | Pharmaceuticals & Biotechnology |
| Book Value | ₹115.19 |
Glaxosmi. Pharma trades with a P/E ratio of 43.31, ROCE of 63.25%, ROE of 52.32%, profit growth of 18.83%, debt-to-equity of 0.02. The FairStock Score of 60/100 suggests mixed fundamentals — some metrics look solid while others need improvement.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer